The bacterial strains used in this study are listed in Table 1. CV026 is a mini-Tn5 mutant of the wild-type strain that lacks AHL synthase and can only produce violacein when the AHL signal molecules is supplied externally (McClean et al., 1997; Kothari et al., 2017). The E. coli strain pSB401 does not produce AHL and contains a plasmid based on LuxR of Vibrio fischeri and luxI promoter controlling luxCDABE expression (Winson et al., 1998). Transformation of DH5α/expI and SCC3065/expI was performed as described previously (Joshi et al., 2020). All strains were cultivated at 28°C in Luria-Bertani (LB) medium (Difco Laboratories, MI, United States). Strain pSB401 was cultivated at 37°C under continuous shaking at 150 rpm in a TU-400 incubator shaker (MRC, Holon, Israel). For the plant-inoculation assay, Murashige and Skoog minimal medium (MS; Duchefa, Haarlem, the Netherlands) was used. Solvents and chemicals were purchased from Sigma-Aldrich (Sigma-Aldrich), ciprofloxacin was purchased from Acros Organics. Phloretin was dissolved in DMSO to a concentration of 145 mM.
Strains used in this study.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.